Back to Research Home

PRVAPrivia Health Group Inc

Health Care · Medical/Nursing Services · Mid

$22.41−2.08%
As of 23 Oct 2026Mkt cap $2.6B
Stage 13
WATCH
Fundamentals
44.1/75
Technical
10.3/15
Independent
54.5/90

GCAE viewtiming is actionable but business strength/confidence is below BUY requirements

Price

1M
+15.6%
3M
−9.2%
6M
−6.0%
1Y
−13.7%

Financials & valuation

Cached filing evidence · as of 2026-10-02

Valuation

P/E
106.7xHist median 180.9x
Forward P/E
—No validated forward-estimate source
Price / FCF
35.8x
FCF yield
2.8%

Quality

ROIC
8.9%
Operating margin
1.2%
FCF margin
4.9%
Current ratio
1.6x

Growth

Revenue growth
+22.3%Latest FY YoY
Revenue CAGR
+21.7%
EPS CAGR
−2.7%
FCF CAGR
+21.7%

Capital

Share-count trend
+1.7%3Y annualised
Net cash
$470M-2.9x OCF

Annual trend

CAGR 2021–2025
+21.7%
Latest · 2025
$2B
YoY
+22.3%
Quality Research
PRE-AI
Acceleration Radar
FUNDAMENTAL GATE FAIL
THE ONE
NOT FLAGGED
Final / Opportunity
NOT FLAGGED

Key takeaway

timing is actionable but business strength/confidence is below BUY requirements

Unresolved question

No reliable unresolved question is available from the current committed evidence.

Watch next

  • Next earnings · 2026-11-05
More details & evidence

Production decision

Stage 13
WATCH
Technical state
early-recovery
Rotation
tailwind
Evidence
fresh

Presentation freshness

Stage 11 market
2026-10-23 · Massive
Financial cache
2026-10-02
Quality Research
CURRENT
THE ONE
NOT FLAGGED

Authority

Company page
Presentation only
Scores
Frozen GCAE production outputs
Research
Research-only lanes; no score override
Private portfolio
Not loaded